Dafalgan, Suppositorien 150 mg

7680475050385 CH-47505 Suppositorien

Associated product:

DAFALGAN supp 150 mg 10 pce
Dafalgan, Suppositorien 150 mg
Dafalgan, Suppositorien 150 mg
Dafalgan, Suppositorien 150 mg
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Suppositorien
Galenic form
Suppositorien
Galenic group
Suppositorien

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/05/2025
Patient information leaflet
Français
07/05/2025
Patient information leaflet
Italien
07/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2.35
Specialties list
Yes
Generic
No
SL addition date: 15/03/1995

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
47505
Drug name
Dafalgan, Suppositorien
Galenic form
SUPP
ATC Code
N02BE01
Authorization status
Z
Dispensing category
D
First authorization
26/11/1986
Authorization expiration date
31/12/9999
IT Number
01.01.1.
Domain
Human medicine
Field of application
Analgetikum, Antipyretikum

Package details

Description (FR)
DAFALGAN supp 150 mg 10 pce
Description (DE)
DAFALGAN Supp 150 mg 10 Stk
Market launch
26/11/1986
Narcotic (BTM)
No

Other package sizes (3)

DAFALGAN supp 80 mg 10 pce
10 SUP
GTIN: 7680475050118
View
DAFALGAN supp 300 mg 10 pce
10 SUP
GTIN: 7680475050460
View
DAFALGAN supp 600 mg 10 pce
10 SUP
GTIN: 7680475050545
View